Compositions and methods for treatment of cardiovascular disease

Details for Australian Patent Application No. 2010238644 (hide)

Owner InVasc Therapeutics, Inc.

Inventors Ragagopal, Desikan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010238644

PCT Pub. Number WO2010/124201

Priority 61/214,425 23.04.09 US

Filing date 23 April 2010

Wipo publication date 28 October 2010

International Classifications

C07D 317/46 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 405/02 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/124201 Priority application(s): WO2010/124201

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010238646-Agglomerate formulations including active pharmaceutical agents with targeted particle sizes

2010238641-Agglomerate formulations useful in dry powder inhalers